Navigation Links
Gains Made in Lung Cancer Survival
Date:12/2/2009

Modest improvement seen for advanced cases, study finds

WEDNESDAY, Dec. 2 (HealthDay News) -- In the past two decades, survival rates for advanced lung cancer patients in the United States have improved modestly, a new study has found.

Researchers analyzed data on more than 100,000 patients diagnosed with stage 4 non-small cell lung cancer (NSCLC) between 1990 and 2005. The patient information was in the U.S. National Cancer Institute's Surveillance, Epidemiology and End Results database.

The study found that one-year overall survival increased from 13.2 percent in 1990 to 19.4 percent in 2005, while two-year overall survival increased from 4.5 percent to 7.8 percent.

The researchers said the improved survival rates may come from changes in the management of advanced NSCLC over the past two decades, including new chemotherapy agents and regimens, increased use of salvage chemotherapy and the introduction of molecularly targeted therapies.

"Although the development of several new agents led to a statistically significant survival improvement between 1990 and 2005, it is sobering that the one-year survival has improved by only 6 percent during this time," study author Dr. Daniel Morgensztern, of the Washington University School of Medicine, said in a news release from the International Association for the Study of Lung Cancer. "Real progress can only be achieved with a better understanding of tumor biology and development of [new] therapies."

The study is published in the December issue of the Journal of Thoracic Oncology.

More information

The U.S. National Cancer Institute has more about lung cancer.



-- Robert Preidt



SOURCE: International Association for the Study of Lung Cancer, news release, Dec. 1, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. DNA vaccine against multiple sclerosis appears safe, potentially beneficial
2. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
3. Despite overeating, morbidly obese mice gain protection against diabetes
4. Alvarado Hospital Files Countersuit Against Blue Shield
5. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
6. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
7. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
8. Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
9. $52.5 Million Settlement Against Sepracor Inc. Approved
10. The fight against colorectal cancer
11. Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... May 31, 2016 , ... When MetLoop ... knew it was something that contractors should have at their disposal on a ... says Butch, CertainTeed’s Director of Contractor Programs. , As a result, Metloop ...
(Date:5/31/2016)... ... May 31, 2016 , ... The successful implementation of “lean manufacturing” in ... well. However, laboratories have different challenges compared to manufacturing environments. , In order ... lab, METTLER TOLEDO has developed the Lean Lab Checklist . This checklist will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... Spectrum Aquatics has ... new lift has been designed and built with the user in mind. , “Over ... consultants have informed us that an ADA 400 lbs lift is a necessary requirement ...
(Date:5/31/2016)... ... ... a recent interview on The Greenburgh Report radio show hosted by Greenburgh, NY Town ... leading medical insurance advocate Adria Goldman Gross discussed several eye-opening issues that have combined ... the interview with Mr. Feiner that aired on May 7, 2016, Ms. Gross, the ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... on patients with cancer, has added Cancer and Careers to its ... more timely content on continuing successful careers while fighting cancer. , As partners, ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Kitov Pharmaceuticals ... late-stage drug development, today announced the completion of ... batches required for registration of KIT-302 with the ... Kitov,s announcement in December 2015, that ... primary efficacy endpoint. "We are fortunate ...
(Date:5/26/2016)... India , May 26, 2016 ... drugs market growth is the emergence of new treatments. ... astaxanthin therapies for osteoarthritis treatment. The therapy is expected ... Moreover, Arthritis Research UK is conducting studies to develop ... arcOGEN study, where the genes involved in osteoarthritis are ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology: